Year: 2019

La Banque Postale and the Groupama Group have signed a non-binding memorandum of understanding covering the acquisition by La Banque Postale of Groupama’s 35% interest in La Banque Postale IARD (LBP IARD) and their extended cooperation in the areas of legal protection and assistance services.LBP IARD, which was set up in late 2009 as a joint venture between La Banque Postale and the Groupama Group, markets property & casualty insurance products and services to La Banque Postale’s retail customers. With over 500 employees and an insurance portfolio comprising 1.8 million policies, LBP IARD has become an independent full-service insurance company.Contractual relations between LBP IARD and the Groupama Group also include service agreements and reinsurance treaties with two Groupama subsidiaries, Groupama PJ (for legal...

La Banque Postale et le Groupe Groupama annoncent avoir signé un protocole d’accord non-engageant pour l’acquisition, par La Banque Postale, de la participation de 35% détenue par Groupama dans La Banque Postale IARD et la prolongation de leur coopération dans les domaines de la protection juridique et de l’assistance.Créée conjointement fin 2009 par La Banque Postale et le Groupe Groupama, LBP IARD commercialise une offre de produits et services d’assurance-dommages à destination des clients particuliers de La Banque Postale.Avec plus de 500 collaborateurs au service d’un portefeuille de 1,8 million de contrats, La Banque Postale IARD est devenue une compagnie d’assurance autonome de plein exercice.Les relations contractuelles entre LBP IARD et le Groupe Groupama...

Oxurion NV to Focus Clinical Development on Molecules Targeting VEGF Independent Pathways for Treatment of DMEPipeline to focus on clinical development of THR-149 and THR-687 No further investment in the clinical development of THR-317 Commercialization of JETREA to be shifted to distributors/ licensees in marketed territories, patient access to be maintained                          Leuven, Belgium, 19 December 2019 – 17:45 CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative back of the eye treatments to preserve vision in patients with diabetic eye disease, announces it is to focus its activities on the clinical development of THR-149 and THR-687...

Communiqué de presse – jeudi 19 décembre 2019 – 17h45ARGAN livre un nouvel entrepôt de 13 000 m² près de Lyon, le quatrième de l’année 2019Quelques jours après la livraison d’un entrepôt à Niort, ARGAN maintient son rythme élevé d’inaugurations avec un nouveau développement sur la commune d’Albon (26) à une soixantaine de kilomètres au sud de Lyon.ARGAN, loueur-développeur d’entrepôts logistiques PREMIUM, annonce avoir livré un nouveau bâtiment logistique sur la commune d’Albon (26), à une soixantaine de kilomètres au sud de Lyon. Cette plateforme de 13 000 m², idéalement située en bordure d’autoroute A7, est intégralement...

Netevia HQ empowers small and regional banks to provide merchant acquiring and innovative payment services to attract Fintech startupsMIAMI, FL, Dec. 19, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, announces the launch of its merchant acquiring enablement services for small and regional banks in the US.  Complete business branding solution to assist banks develop their brand identity Management of ISOs with an unlimited number of Sub-ISOs and Agents Built-in support system Quick access to documents and...

CALGARY, Alberta, Dec. 19, 2019 (GLOBE NEWSWIRE) — Essential Energy Services Ltd. (TSX: ESN) (“Essential” or the “Company”) announces its patent litigation win and its 2020 capital budget.PATENT LITIGATION WINSupreme Court RulingOn December 19, 2019, the Supreme Court of Canada (the “Supreme Court”) ruled that it will not grant leave to hear an appeal by Packers Plus Energy Services Inc. (“Packers Plus”) of the Federal Court’s judgment in a patent infringement action against Essential. As a result, Packers Plus has no further avenues of recourse against Essential in respect of its patent. “This is fantastic news for Essential,” commented Garnet Amundson, President and Chief Executive Officer. “We have spent over six years fighting this case and are delighted...

Copenhagen, Dec. 19, 2019 (GLOBE NEWSWIRE) —  Opdateret prospekt og central investorinformation for Investeringsforeningen Nielsen Global Value i likvidation offentliggøres dags dato.Prospekt er opdateret med nye emission- og indløsningssatser samt ÅOP.Dokumenterne kan downloades fra www.nielsenglobalvalue.dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Med venlig hilsenBI Management A/SMalene EhrenskjöldDirektørVedhæftede filerProspekt NGV 2019.12.19 cleanVedtægter INV Nielsen Global Value I LIKVIDATION – godkendt af FT d. 7. sep. 2018

Copenhagen, Dec. 19, 2019 (GLOBE NEWSWIRE) —Opdateret prospekt og væsentlig investorinformation for Kapitalforeningen Blue Strait Capital offentliggøres dags dato.Prospekt er opdateret med nye emission- og indløsningssatser samt ÅOP. Endvidere er afsnittet om investeringsstrategi præciseret.Dokumenterne kan downloades fra www.bluestraitcapital. dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Vedhæftede filerProspekt Kap. Blue Strait Capital 2019.12.19 CleanVedtægter Kapitalforeningen Blue Strait Capital 2018.04.20 underskrevet

JSC Olainfarm informs that in 2020 disclosure of financial results is scheduled for the following dates:Unaudited consolidated interim financial statements for 12 months – on 28 February 2020;Unaudited consolidated interim financial statements for 3 months – on 29 May 2020;Unaudited consolidated interim financial statements for 6 months – on 31 August 2020;Unaudited consolidated interim financial statements for 9 months – on 30 November 2020.Audited consolidated and unconsolidated Annual Report of JSC Olainfarm for 2019 submission planned on 30 April 2020.JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective...

AS “Olainfarm” informē, ka 2020.gadā finanšu rezultātu publicēšana plānota šādos datumos:Neauditēts 2019.gada finanšu pārskats – 2020. gada 28. februārī;Neauditēts 2020. gada 3 mēnešu starpperioda konsolidēts finanšu pārskats – 2020. gada 29.maijā;Neauditēts 2020. gada 6 mēnešu starpperioda konsolidēts finanšu pārskats – 2020. gada 31.augustā;Neauditēts 2020. gada 9 mēnešu starpperioda konsolidēts finanšu pārskats – 2020. gada 30.novembrī.AS “Olainfarm” auditētu 2019.gada konsolidēto un nekonsolidēto finanšu pārskatu publicēs 2020.gada 30.aprīlī.AS „Olainfarm“...